{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:40:50Z","timestamp":1764103250601},"reference-count":20,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Xenobiotica"],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.1080\/00498254.2021.2020377","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T19:39:22Z","timestamp":1639769962000},"page":"1470-1474","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Meeting report: 3rd workshop of the peptide ADME discussion group"],"prefix":"10.1080","volume":"51","author":[{"given":"Anders","family":"Sonesson","sequence":"first","affiliation":[{"name":"Global DMPK, Ferring Pharmaceuticals, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Bj\u00f8rnsdottir","sequence":"additional","affiliation":[{"name":"Development ADME, Novo Nordisk A\/S, M\u00e5l\u00f8v, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Kammersgaard","family":"Christensen","sequence":"additional","affiliation":[{"name":"Development ADME, Novo Nordisk A\/S, M\u00e5l\u00f8v, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,12,27]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-007-0665-4"},{"key":"CIT0002","unstructured":"[DMDG] Drug Metabolism Discussion Group 2021. Available from: www.dmdg.org. [last accessed 8 December ]."},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1186\/cc7922"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.07.009"},{"key":"CIT0005","unstructured":"[EMA] European Medicines Agency 2012. Guideline on the investigation of drug interactions, Available from: www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-investigation-drug-interactions-revision-1_en.pdf. [last accessed 8 December 2021]."},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1186\/s40348-016-0044-8"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.086397"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181a00a1c"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.087148"},{"key":"CIT0010","unstructured":"NCT01000649 2021. Effects of the V1a Agonist FE 202158 in patients with septic shock. [Accessed 8 December]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01000649?term=NCT01000649&draw=2&rank=1"},{"key":"CIT0011","unstructured":"NCT01612676 2021. Investigating FE 202158 as potential primary treatment in patients with early septic shock [Accessed 8 December]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01612676?term=NCT01612676&draw=2&rank=1"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1798-7"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113191"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-1396"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2020.1784496"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2020.1729447"},{"key":"CIT0017","unstructured":"[FDA] US Food and Drug Administration 2020a. Clinical Drug Interaction Studies - Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industry. [Accessed 8 December 2021]. www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-drug-interaction-studies-cytochrome-p450-enzyme-and-transporter-mediated-drug-interactions"},{"key":"CIT0018","unstructured":"[FDA] US Food and Drug Administration 2020b. In\u00a0Vitro Drug Interaction Studies- Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions. [Accessed 8 December 2021]. www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/vitro-drug-interaction-studies-cytochrome-p450-enzyme-and-transporter-mediated-drug-interactions"},{"key":"CIT0019","unstructured":"[FDA] US Food and Drug Administration 2020c. Drug-Drug Interaction Assessment for Therapeutic Proteins Guidance for Industry. Draft guideline [Accessed 8 December 2021]. www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/drug-drug-interaction-assessment-therapeutic-proteins-guidance-industry"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201611914"}],"container-title":["Xenobiotica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00498254.2021.2020377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T14:05:44Z","timestamp":1645452344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00498254.2021.2020377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,2]]}},"alternative-id":["10.1080\/00498254.2021.2020377"],"URL":"https:\/\/doi.org\/10.1080\/00498254.2021.2020377","relation":{},"ISSN":["0049-8254","1366-5928"],"issn-type":[{"value":"0049-8254","type":"print"},{"value":"1366-5928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}